leisure time -WSS

leisure time

author：explore 2025-08-28 08:47:03 - browse：3352

Colorful illustration of scientists using computers and Artificial Intelligence technology to visualize proteins for drug development – biotech coverage from STAT — Mike Reddy for STAT

David Reese calls it a “hinge moment” — the turning point when biotech and big tech merge to attack human disease with artificial intelligence.

At Amgen, where he’s led drug research and development since 2018, Reese said this moment has finally arrived. The proof lies not only in organizational changes, such as his recent appointment as the company’s first chief technology officer, but also in Amgen’s broader push to embed AI into every aspect of the drug discovery process.

“We’re now seeing 10-fold improvements in these (AI) models every six months,” said Reese, a medical oncologist by training. He added that the quickening pace of advancement means investing in the technology is no longer optional: “It’s something we must do to have a practical, pragmatic impact on drug discovery.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Arc Institute generative AI designs new CRISPR systems

focus

WSS

Report: NIH

Insmed lung disease drug hits target in key Phase 3 trial

Venture capitalist Bob Kocher on the state of digital health

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Insmed lung disease drug hits target in key Phase 3 trial

Addiction doctors spar with methadone clinics over legislation

entertainment

leisure time

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Biohaven protein

Medicare proposal to cover medical devices draws a mixed reaction

Bird flu: Don't repeat Covid's 'health versus the economy' framing

United colonoscopy coverage change 'may cost lives,' doctors say

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Bright Health sells Medicare Advantage business to Molina

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Malaria cases in Florida and Texas: Here’s what you need to know

Big Tobacco's 'harm reduction': Is it for real, or a sham?

leisure time

Helping hospitals and community health centers plan for resilience

Stigma and the return of syphilis

NVIDIA and Google execs on the future of AI and drug discovery

Childbirth

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Addiction experts warn against a second 'war on drugs'

focus

hotspot

focus

hotspot